{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:15:38Z","timestamp":1791836138845,"version":"4.3.4"},"reference-count":28,"publisher":"Wiley","issue":"24","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infections are a leading cause of death in patients with cancer, but the proportion and rate of antimicrobial resistance (AMR) in hospitalized patients with cancer are not well understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, cross\u2010sectional evaluation of AMR assessed hospitalized adult patients in 168 United States (US) healthcare facilities between April 2018 and December 2022. Nonduplicate, noncontaminant Gram\u2010negative and Gram\u2010positive bacteria recovered from various samples (blood, respiratory, urine, etc.) were used to assess the rate of AMR pathogens per 1000 admissions and the proportion of AMR among bacterial isolates in patients with and without cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      Among 4,612,620 admissions, 6.4% (297,500) were of patients with cancer and 93.6% (4,315,120) were of patients without cancer. AMR pathogen rates were higher in cancer patients than patients without cancer for most pathogen groups, including vancomycin\u2010resistant enterococci with incidence rate ratio (IRR), 1.95 (95% confidence interval [CI], 1.84, 2.07), extended\u2010spectrum beta\u2010lactamase (ESBL) producers (IRR, 1.48 [95% CI, 1.43, 1.53]), carbapenem\u2010nonsusceptible\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      (IRR, 1.46 [95% CI, 1.32, 1.61]), and multidrug\u2010resistant\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      <\/jats:styled-content>\n                      (IRR, 1.31 [95% CI, 1.18, 1.45]). The percentage of nonsusceptible isolates in most pathogen groups was lower in patients with versus without cancer except for ESBL producers among\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      (odds ratio (OR), 1.11 [95% CI, 1.07, 1.15]) and vancomycin resistance among enterococci (OR, 1.22 [95% CI, 1.14, 1.30]), which were higher in cancer patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AMR rates for certain key pathogens were 1.5\u20132 times greater in hospitalized cancer patients compared to hospitalized noncancer patients. The increased AMR rate in cancer patients highlights the need for enhanced infection prevention and diagnostic stewardship efforts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cam4.70495","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T02:08:48Z","timestamp":1734142128000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Burden of Antimicrobial Resistance in Adult Hospitalized Patients With Cancer: A Multicenter Analysis"],"prefix":"10.1002","volume":"13","author":[{"given":"Vikas","family":"Gupta","sequence":"first","affiliation":[{"name":"Becton, Dickinson and Company  Franklin Lakes NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Satlin","sequence":"additional","affiliation":[{"name":"Transplant\u2010Oncology Infectious Diseases Program, Division of Infectious Diseases Weill Cornell Medicine  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalvin","family":"Yu","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company  Franklin Lakes NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehoda M.","family":"Martei","sequence":"additional","affiliation":[{"name":"Department of Medicine (Hematology\u2010Oncology Division) University of Pennsylvania  Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0951-3091","authenticated-orcid":false,"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[{"name":"Division of Haematology\/Oncology The Hospital for Sick Children  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars F.","family":"Westblade","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Weill Cornell Medicine  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Howard","sequence":"additional","affiliation":[{"name":"Resonance Inc.  Arlington TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChinEn","family":"Ai","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company  Franklin Lakes NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6229-4618","authenticated-orcid":false,"given":"Diane C.","family":"Flayhart","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company  Franklin Lakes NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(21)02724\u20100"},{"key":"e_1_2_11_3_1","volume-title":"Antibiotic Resistance Threats in the United States","author":"CDC","year":"2019"},{"key":"e_1_2_11_4_1","article-title":"Tackling Drug\u2010Resistant Infections Globally: Final Report and Recommendations","author":"O'Neill J.","year":"2016","journal-title":"Government of the United Kingdom"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121\u2010021\u201000433\u20107"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520\u2010022\u201007392\u2010w"},{"key":"e_1_2_11_7_1","unstructured":"UICC Antimicrobial Resistance and Its Impact on Cancer Careaccessed July 31 2024 https:\/\/www.uicc.org\/what\u2010we\u2010do\/thematic\u2010areas\/antimicrobial\u2010resistance\u2010amr#_ftn4."},{"key":"e_1_2_11_8_1","unstructured":"Norwegian Cancer Society What Are the Consequences of Antibiotic Resistance for Cancer Patients? accessed July 30 2024 https:\/\/kreftforeningen.no\/en\/antimicrobial\u2010resistance\u2010amr\/consequences\u2010of\u2010antibiotic\u2010resistance\/."},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21697"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab560"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac537"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac039"},{"key":"e_1_2_11_13_1","unstructured":"NIH A to Z List of Cancer DrugsUpdated April 4 2023. accessed August 24 2023 https:\/\/www.cancer.gov\/about\u2010cancer\/treatment\/drugs."},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1309\/502AUPR8VE67MBDE"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc2893"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096\u2010013\u20101819\u20107"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8883700"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520\u2010013\u20102012\u20103"},{"key":"e_1_2_11_19_1","unstructured":"WHO Sepsis (Fact Sheet)accessed August 10 2023 https:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/sepsis."},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.07.002"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2015.00011"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2017.1153"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8030106"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00366"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.6211"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(15)00270\u20104"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw113"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.636547"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed6020049"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.70495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T03:56:30Z","timestamp":1738900590000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.70495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":28,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1002\/cam4.70495"],"URL":"https:\/\/doi.org\/10.1002\/cam4.70495","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-08-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70495"}}